The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease
Open accessAbstract
Cholinergic transmission at muscarinic acetylcholine receptors (mAChR) has been implicated in higher brain functions such as learning and memory, and loss of synapses may contribute to the symptoms of Alzheimer disease. A heterogeneous family of five genetically distinct mAChR subtypes differentially modulate a variety of intracellular signaling systems as well as the processing of key molecules involved in the pathology of the disease. Although many muscarinic effects have been identified in memory circuits, including a diversity of pre- and post-synaptic actions in hippocampus, the identities of the molecular subtypes responsible for any given function remain elusive. All five mAChR genes are expressed in hippocampus, and subtype-specific antibodies have enabled identification, quantification, and localization of the encoded proteins. The m1, m2, and m4 mAChR proteins are most abundant in forebrain regions and they have distinct cellular and subcellular localizations suggestive of various pre- and postsynaptic functions in cholinergic circuits. The subtypes are also differentially altered in postmortem brain samples from Alzheimer disease cases. Further understanding of the molecular pharmacology of failing synapses in Alzheimer disease, together with the development of new subtype-selective drugs, may provide more specific and effective treatments for the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Self-citationAlzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Identification of a Family of Muscarinic Acetylcholine Receptor Genes
Bonner, T. I., Buckley, N. J., Young, A. C., & Brann, M. R. (1987) · Science · doi:10.1126/science.3037705 · Cited by 1,427
Human Memory and the Cholinergic System: A Relationship to Aging?
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,397
Hulme, E. C., Birdsall, N. J. M., & Buckley, N. J. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.003221 · Cited by 1,338
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Levey, A., Kitt, C., Simonds, W., Price, D., & Brann, M. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-10-03218.1991 · Cited by 918
Self-citationArendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817
Peralta, E. G., Ashkenazi, A., Winslow, J. W., Smith, D. H., Ramachandran, J., & Capon, D. J. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02733.x · Cited by 763
Mash, D. C., Flynn, D. D., & Potter, L. T. (1985) · Science · doi:10.1126/science.3992249 · Cited by 698
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
Davis, K. L., Thal, L. J., Gamzu, E. R., Davis, C. S., Woolson, R. F., Gracon, S. I., Drachman, D. A., Schneider, L. S., Whitehouse, P. J., Hoover, T. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271801 · Cited by 626
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
Dörje, F., Wess, J., Lambrecht, G., Tacke, R., Mutschler, E., & Brann, M. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23208-6 · Cited by 610
Dunnett, S. B. (1985) · Psychopharmacology · doi:10.1007/bf00432721 · Cited by 484
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.
Weiner, D. M., Levey, A. I., & Brann, M. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7050 · Cited by 480
Self-citationLocalization of a family of muscarinic receptor mRNAs in rat brain
Buckley, N., Bonner, T., & Brann, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04646.1988 · Cited by 476
Morris, J. C., McKeel, D. W., Storandt, M., Rubin, E. H., Price, J. L., Grant, E. A., Ball, M. J., & Berg, L. (1991) · Neurology · doi:10.1212/wnl.41.4.469 · Cited by 473
Amnesia Following Basal Forebrain Lesions
Damasio, A. R., Graff-Radford, N. R., Eslinger, P. J., Damasio, H., & Kassell, N. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060030081013 · Cited by 473
Levey, A., Edmunds, S., Koliatsos, V, Wiley, R., & Heilman, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04077.1995 · Cited by 422
Self-citationHersch, S., Gutekunst, C., Rees, H., Heilman, C., & Levey, A. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03351.1994 · Cited by 404
Self-citationA Controlled Trial of Tacrine in Alzheimer's Disease
Farlow, M. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490180055026 · Cited by 398
Presynaptic inhibitory effect of acetylcholine in the hippocampus
Valentino, R., & Dingledine, R. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-07-00784.1981 · Cited by 345
Raiteri, M., Leardi, R., & Marchi, M. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21528-2 · Cited by 314
Essential role of neocortical acetylcholine in spatial memory
Winkler, J., Suhr, S. T., Gage, F. H., Thal, L. J., & Fisher, L. J. (1995) · Nature · doi:10.1038/375484a0 · Cited by 311
Mrzljak, L., Levey, A. I., & Goldman-Rakic, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5194 · Cited by 256
Self-citationDifferential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease
Flynn, D. D., Ferrari‐DiLeo, G., Mash, D. C., & Levey, A. I. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041888.x · Cited by 234
Self-citationYasuda, R. P., Ciesla, W., Flores, L. R., Wall, S. J., Li, M., Satkus, S. A., Weisstein, J. S., Spagnola, B. V., & Wolfe, B. B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13594-3 · Cited by 217
Etienne, P., Robitaille, Y., Wood, P., Gauthier, S., Nair, N. P. V., & Quirion, R. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90142-9 · Cited by 213
Lehéricy, S., Hirsch, É. C., Cervera‐Piérot, P., Hersh, L. B., Bakchine, S., Piette, F., Duyckaerts, C., Hauw, J., Javoy‐Agid, F., & Agid, Y. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903300103 · Cited by 207
Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system
Nilsson, O. G., Leanza, G., Rosenblad, C., Lappi, D. A., Wiley, R. G., & Björklund, A. (1992) · NeuroReport · doi:10.1097/00001756-199211000-00015 · Cited by 206
Neuroreceptor changes in Alzheimer disease.
Nordberg, A. K. (1992) · PubMed · Cited by 162
Regulated secretion of beta-amyloid precursor protein in rat brain
Farber, S., Nitsch, R., Schulz, J., & Wurtman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07442.1995 · Cited by 158
Markram, H., & Segal, M. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019015 · Cited by 158
Clinical Correlates of Cortical and Nucleus Basalis Pathology in Alzheimer Dementia
Samuel, W., Terry, R. D., DeTeresa, R. M., Butters, N., & Masliah, E. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540200048015 · Cited by 158
Localization of muscarinic M3 receptor protein and M3 receptor binding in rat brain
Levey, A. I., Edmunds, S. M., Heilman, C. J., Desmond, T. J., & Frey, K. A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90017-5 · Cited by 148
Self-citationFlynn, D. D., Weinstein, D. A., & Mash, D. C. (1991) · Annals of Neurology · doi:10.1002/ana.410290305 · Cited by 146
Sadot, E., Gurwitz, D., Barg, J., Behar, L., Ginzburg, I., & Fisher, A. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66020877.x · Cited by 139
Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
Bymaster, F. P., Heath, I., Hendrix, J., & Shannon, H. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39340-7 · Cited by 138
Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine
Hagan, J. J., Jansen, J. H. M., & Broekkamp, C. L. E. (1987) · Psychopharmacology · doi:10.1007/bf00207237 · Cited by 136
Levey, A. I., Edmunds, S. M., Hersch, S. M., Wiley, R. G., & Heilman, C. J. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903510303 · Cited by 127
Self-citationLapchak, P. A., Araujo, D. M., Quirion, R., & Collier, B. (1989) · Brain Research · doi:10.1016/0006-8993(89)91075-5 · Cited by 117
Richards, M. H. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb13002.x · Cited by 98
Dawson, G. R., & Iversen, S. D. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90130-i · Cited by 90
Carbachol depresses synaptic responses in the medial but not the lateral perforant path
Kahle, J. S., & Cotman, C. W. (1989) · Brain Research · doi:10.1016/0006-8993(89)90554-4 · Cited by 87
Chapter 34: Central cholinergic mechanisms and function
Krnjević, K. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62410-3 · Cited by 82
Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory
Packard, M. G., Regenold, W. T., Quirion, R., & White, N. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90493-u · Cited by 72
Muscarinic depression of synaptic transmission at the hippocampal mossy fiber synapse
Williams, S., & Johnston, D. (1990) · Journal of Neurophysiology · doi:10.1152/jn.1990.64.4.1089 · Cited by 60
Chapter 28 Physiological mechanisms of cholinergic action in the hippocampus
Halliwell, J. V. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)60910-3 · Cited by 57
Cell Loss from the Nucleus Basalis of Meynert in Alzheimer's Disease
Doucette, R., Fisman, M., Hachinski, V. C., & Mersky, H. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037070 · Cited by 57
Vilaró, M. T., Mengod, G., & PALACIOS, J. M. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62385-7 · Cited by 56
Herreras, Ó., Solís, J. M., Herranz, A. S., del Río, R. M., & Lerma, J. (1988) · Brain Research · doi:10.1016/0006-8993(88)90260-0 · Cited by 54
Presynaptic Muscarinic Receptors in the Central Nervous Systema
Raiteri, M., Marchi, M., & Paudice, P. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb31987.x · Cited by 53
Messer, W. S., Thomas, G. J., & Hoss, W. P. (1987) · Brain Research · doi:10.1016/0006-8993(87)91217-0 · Cited by 48
Chapter 40: Muscarinic receptor subtype-specific coupling to second messengers in neuronal systems
McKinney, M. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62416-4 · Cited by 48
Wang, S. Z., Zhu, S.-Z., Mash, D. C., et al. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90194-g · Cited by 28
Cited by
Cholinergic modulation of the hippocampal region and memory function
Haam, J., & Yakel, J. L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14052 · Cited by 450
Pavlov, V. A., Parrish, W. R., Rosas-Ballina, M., Ochani, M., Puerta, M., Ochani, K., Chavan, S., Al-Abed, Y., & Tracey, K. J. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.06.011 · Cited by 435
The cholinergic system in Alzheimer's disease
Kása, P., Rakonczay, Z., & Gulya, K. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00028-2 · Cited by 409
G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors
Lu, W.-Y., Xiong, Z.-G., Lei, S., Orser, B. A., Dudek, E., Browning, M. D., & MacDonald, J. F. (1999) · Nature Neuroscience · doi:10.1038/7243 · Cited by 374
Maelicke, A., Samochocki, M., Jostock, R., Fehrenbacher, A., Ludwig, J., Albuquerque, E. X., & Zerlin, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01109-4 · Cited by 303
Metadata
- Authors
- Levey, A. I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-11-26
- Volume
- 93
- Issue
- 24
- Pages
- 13541-13546
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2014127226
- Cited by
- 359
- References
- 59
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.